Teyro Labs Private Limited – FDA 483, Nov 12, 2025
Teyro Labs Private Limited in Kanchivakkam, India, was inspected by the FDA from November 3-12, 2025, revealing significant deficiencies in sterile drug manufacturing. The inspection found issues with equipment qualification, personnel gowning, equipment cleaning and maintenance, process validation, and investigation of discrepancies, indicating a lack of adequate controls to ensure drug product quality and sterility. These observations highlight serious concerns regarding the firm's adherence to cGMP regulations.
ID · bcfa7d8d-c986-4393-85f1-2b576ee49dda
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.